This new report from Venture Planning Group provides analysis of BUN (Blood Urea Nitrogen) testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals
- Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices
- Ambulatory Care Centers
- ICUs/CCUs
- Emergency Departments
- Operating and Recovery Suites
- Surgery Centers
- Nursing Homes
- Birth Centers List of Tables France: BUN (Blood Urea Nitrogen) Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018 Germany: BUN (Blood Urea Nitrogen) Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018 Italy: BUN (Blood Urea Nitrogen) Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018 Japan: BUN (Blood Urea Nitrogen) Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018 Spain: BUN (Blood Urea Nitrogen) Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018 UK: BUN (Blood Urea Nitrogen) Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018 USA: BUN (Blood Urea Nitrogen) Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
|